German Healthtech Stock News

Fresenius Medical Care (XTRA:FME) is back in focus after a recent share move, with the stock closing at €38.40 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Fresenius Medical Care. That latest move to €38.40 comes after a 7.22% 1 month share price decline and a 4.41% year to date share price pullback. The 1 year total shareholder return of a 12.80% decline contrasts with a 3 year total shareholder return of a 9.34% gain. If this kind of...

Vossloh AG ( ETR:VOS ) last week reported its latest yearly results, which makes it a good time for investors to dive...

Why the DG Matrix partnership matters for Infineon Technologies stock Infineon Technologies (XTRA:IFX) is in focus after DG Matrix agreed to use its latest-generation silicon carbide MOSFETs in the Interport solid-state transformer platform for AI data centers and electrification projects worldwide. This agreement links Infineon directly to power infrastructure for AI workloads and utility microgrids, an area investors increasingly watch when assessing how chipmakers are positioned across...

Fourth quarter results put Brenntag (XTRA:BNR) under closer scrutiny Brenntag (XTRA:BNR) moved into focus after fourth quarter 2025 earnings showed sales of €3,512 million compared with €3,989.7 million a year earlier, and a net loss of €23.5 million replacing prior net income. See our latest analysis for Brenntag. The latest quarterly loss has sharpened attention on Brenntag, yet the share price has recently moved higher, with a 7 day share price return of 13.86% and a 90 day share price...

Bechtle earnings trigger fresh look at the stock Bechtle (XTRA:BC8) released full year 2025 results with sales of €6,405.87m versus €6,305.76m a year earlier, while net income and basic earnings per share were lower than the prior year. See our latest analysis for Bechtle. The latest full year earnings release appears to have reset expectations, with a 6.1% 1 day share price return, but a 36.3% year to date share price decline and a 22.8% 1 year total shareholder return decline suggesting...

Why Nordex stock is drawing attention after a wave of new orders Nordex (XTRA:NDX1) has been in focus after a series of new turbine orders in Germany and Serbia, including projects with Prowind, repowering work on Fehmarn island, and a community wind farm in North Rhine-Westphalia. See our latest analysis for Nordex. These new German and Serbian orders have arrived alongside strong market interest, with the share price at €45.4 and a 30 day share price return of 34.8%, while the 1 year total...

Knorr-Bremse AG has released its full-year 2025 results, reporting revenue of €7,869 million, net income of €534 million, and basic earnings per share of €3.31, alongside declaring an annual dividend of €1.90 per share payable on May 6, 2026. The combination of higher net income and earnings per share despite slightly lower revenue, together with the confirmed dividend, highlights management’s emphasis on profitability and returning cash to shareholders. With profitability improving even as...

Jenoptik (XTRA:JEN) is in focus after full year 2025 earnings showed lower sales and net income, coinciding with its move from the SDAX to the MDAX and recent operational improvements. See our latest analysis for Jenoptik. The share price reaction has been strong, with a 14.57% 1 day share price return and 52.00% 90 day share price return, while the 1 year total shareholder return sits at 34.89%, suggesting momentum has picked up recently. If Jenoptik’s recent swing has your attention, it can...

A.S. Création Tapeten AG ( ETR:ACWN ) is possibly approaching a major achievement in its business, so we would like to...

INDUS Holding (XTRA:INH) has put fresh numbers on the table for FY 2025, with third quarter revenue of €439.8 million and basic EPS of €1.33, setting the tone for how the rest of the year is shaping up. The company has seen quarterly revenue range from €403.6 million to €443.9 million over the past six reported periods, while basic EPS has moved between €0.18 and €1.33. This gives investors a clear view of how the top line and per share earnings have tracked across recent quarters. With a...

SAP (XTRA:SAP) announced new partnerships with LatticeFlow AI and Prismforce to expand AI governance and workforce intelligence capabilities within its ecosystem. The LatticeFlow AI collaboration focuses on operational AI risk management and compliance aligned with regulations such as the EU AI Act. The Prismforce integration aims to provide SAP customers with real time skill mapping and workforce intelligence tools for talent decisions. SAP sits at the center of many core business systems,...

ATOSS Software (XTRA:AOF) has announced an annual dividend of €2.28 per share, with the ex date set for May 4, 2026, the record date on May 5, and payment on May 6. See our latest analysis for ATOSS Software. ATOSS Software’s 1 day share price return of 2.44% comes after a weak run, with a 30 day share price return showing an 8.80% decline and a 1 year total shareholder return showing a 39.80% decline, suggesting recent dividend news has not yet reversed broader negative momentum. If you are...

If you are asking yourself whether BASF at €50.02 is offering value or just fair pricing, this breakdown is for you. The stock has returned 3.6% over the last 7 days, 2.4% over the last 30 days, 11.7% year to date, and 6.0% over the last year. This gives you a useful snapshot of how sentiment has shifted over different time frames. Recent headlines around BASF have focused on broader sector conditions and how large chemicals groups are positioning their portfolios and cost bases. These...

Deutsche Wohnen (XTRA:DWNI) has reported FY 2025 results with second quarter revenue of €450 million and a basic EPS loss of €0.73, as the group continues to work through a period of negative earnings. Over recent periods, revenue has moved from €380.1 million in Q2 2024 to €446.35 million in Q1 2025 and €450 million in Q2 2025. Basic EPS has ranged from a loss of €0.65 per share in Q2 2024 to a loss of €1.53 in Q4 2024 and a loss of €0.73 in the latest quarter, which may prompt investors to...

Rheinmetall stock: context and recent performance Rheinmetall (XTRA:RHM) has drawn fresh attention after recent trading left the shares with a return of about 1% over the past day, set against a month loss near 13% and a past 3 months decline around 4%. See our latest analysis for Rheinmetall. At a share price of €1,486.5, Rheinmetall’s recent 7 day and 30 day share price returns of about 7% and 13% declines contrast with a very large 3 year total shareholder return, suggesting momentum has...

Deutsche Pfandbriefbank (XTRA:PBB) has just reported its FY 2025 results with Q4 total revenue of €52 million and a basic EPS loss of €0.52, while trailing 12 month figures show total revenue of €12 million and a basic EPS loss of €2.30 as profitability pressure remains front and center for shareholders. Over recent quarters, revenue has moved from €110 million in Q3 2024 to €89 million in Q4 2024, then to €92 million in Q1 2025, €209 million in Q2 2025, €77 million in Q3 2025 and €52 million...

LANXESS stock at a glance LANXESS (XTRA:LXS) has been drawing attention after a recent stretch of weak share performance, including negative returns over the past month, past 3 months, and year. This has prompted fresh questions about how investors view the specialty chemicals group. See our latest analysis for LANXESS. At around €13.95, LANXESS has seen a sharp 30-day share price return of about a 29% decline and a 1-year total shareholder return of roughly a 54% loss, which points to fading...

Earnings shock and reduced dividend put K+S (XTRA:SDF) under closer investor scrutiny K+S (XTRA:SDF) has come under pressure after reporting a full year 2025 net loss of €1,075.8 million and confirming a sharply reduced annual dividend of €0.07 per share. The results included sales of €3,647.9 million and a basic loss per share from continuing operations of €6.01. This has set the context for reassessing the stock and its income appeal ahead of the May 2026 payout. See our latest analysis for...

Why Fraport’s latest earnings and dividend move matter for shareholders Fraport (XTRA:FRA) has paired relatively stable 2025 results with its first planned dividend since the COVID-19 pandemic, which is putting fresh attention on the stock’s income potential and earnings resilience. See our latest analysis for Fraport. The share price is now €74.5, and recent moves tell a mixed story. There has been a 10.24% 1 month share price decline, a 7.97% 3 month share price return, and a 28.67% 1 year...

Salzgitter AG has completed a major restructuring that returned its trading business to profitability and exceeded internal cost saving targets. The company secured additional funding for its SALCOS green steel program, bringing total backing for the project to €1.3b. Salzgitter AG rejoined the MDAX index, highlighting its renewed relevance for German mid cap investors. Salzgitter (XTRA:SZG) is entering this phase of change with a share price of €37.28 and a mixed return profile. The stock...

Carl Zeiss Meditec (XTRA:AFX) has drawn fresh attention after expanding its ophthalmology and optometry workflow solutions in Canada, adding new diagnostic systems, laser treatment devices, and data management tools that deepen its presence in eye care technology. See our latest analysis for Carl Zeiss Meditec. The recent Canada workflow expansion comes after Carl Zeiss Meditec was removed from a global FTSE index and then added to the Germany SDAX (Total Return) Index, against a backdrop of...

Hugo Boss plans to phase out regular use of air freight to cut costs and reduce its environmental footprint. The company is also working to streamline its product assortment to sharpen brand focus. These operational changes are being assessed by investors alongside the current share price of €36.78 for XTRA:BOSS. XTRA:BOSS is trading at €36.78, with a 1 year return of 5.8% and a 3 year return showing a 36.2% decline. The mixed track record over recent years means operational moves like...

Drägerwerk KGaA (XTRA:DRW3) just posted its FY 2025 third quarter numbers, with revenue of €833.3 million and net income of €35.7 million setting the tone for a year that has featured positive and loss making quarters alike. Over the past few reporting periods the company has seen quarterly revenue move between €730.3 million and €1.1 billion, while basic EPS for disclosed quarters ranged from €0.60 in Q2 2025 to €4.05 in Q4 2024, giving investors a broad view of how earnings per share can...

It's been a mediocre week for Bechtle AG ( ETR:BC8 ) shareholders, with the stock dropping 13% to €26.44 in the week...